Log on / register
Feedback | Support | My details
Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study.
Atzeni F, Sarzi-Puttini P, Dell' Acqua D, de Portu S, Cecchini G, Cruini C, Carrabba M, Meroni PL
Arthritis Res Ther 2006, 8:R3
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research article
Different properties of ACPA and IgM-RF derived from a large dataset: further evidence of two distinct autoantibody systems
Ursum J, Bos WH, van de Stadt RJ, Dijkmans BAC, van Schaardenburg D
Arthritis Research & Therapy 2009, 11:R75 (21 May 2009)
[Full text] [PubMed Central] [PubMed] [Related articles] [Cited on BioMed Central]
2.


Research article
Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy
Nicaise Roland P, Grootenboer Mignot S, Bruns A, Hurtado M, Palazzo E, Hayem G, Dieudé P, Meyer O, Chollet Martin S
Arthritis Research & Therapy 2008, 10:R142 (10 December 2008)
[Full text] [PubMed Central] [PubMed] [Related articles] [Cited on BioMed Central]

You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.